ALB and acute kidney injury: To our knowledge, the only other trial to assess the use of hyperoncotic albumin in critically ill patients with AKI was an 8 person cross-over study that showed improved hemodynamics if 17.5% albumin was used as the priming solution for hemodialysis in septic patients with AKI [13].